These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15727711)

  • 1. [Pexoxisome proliferator-activated receptor gamma ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats].
    Guo YT; Leng XS; Zhao JM; Lin XH; Li T; Zhu JY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):145-6. PubMed ID: 15727711
    [No Abstract]   [Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma ligand prevents the development of chronic pancreatitis through modulating NF-kappaB-dependent proinflammatory cytokine production and pancreatic stellate cell activation.
    Hisada S; Shimizu K; Shiratori K; Kobayashi M
    Rocz Akad Med Bialymst; 2005; 50():142-7. PubMed ID: 16358954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells.
    Liu J; Lu H; Huang R; Lin D; Wu X; Lin Q; Wu X; Zheng J; Pan X; Peng J; Song Y; Zhang M; Hou M; Chen F
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):400-8. PubMed ID: 15838654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.
    Doi S; Masaki T; Arakawa T; Takahashi S; Kawai T; Nakashima A; Naito T; Kohno N; Yorioka N
    Transplantation; 2007 Jul; 84(2):207-13. PubMed ID: 17667812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats.
    Guo YT; Leng XS; Li T; Zhao JM; Lin XH
    World J Gastroenterol; 2004 Dec; 10(23):3419-23. PubMed ID: 15526359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters by pioglitazone, a ligand of peroxisome proliferator-activated receptor gamma.
    Takeuchi Y; Takahashi M; Sakano K; Mutoh M; Niho N; Yamamoto M; Sato H; Sugimura T; Wakabayashi K
    Carcinogenesis; 2007 Aug; 28(8):1692-6. PubMed ID: 17449904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice.
    Lu J; Imamura K; Nomura S; Mafune K; Nakajima A; Kadowaki T; Kubota N; Terauchi Y; Ishii G; Ochiai A; Esumi H; Kaminishi M
    Cancer Res; 2005 Jun; 65(11):4769-74. PubMed ID: 15930296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
    Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PPAR(gamma) K422Q mutation does not contribute to troglitazone inefficiency in colon cancer treatment.
    Bouancheau D; Buecher B; Jarry A; Simon B; Masson D; Cassagnau E; Hamelin R; Laboisse CL; Bézieau S; Denis MG
    Cancer Lett; 2005 Jun; 224(1):111-6. PubMed ID: 15911106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
    Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Takashima T; Fujiwara Y; Hamaguchi M; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Higuchi K; Arakawa T
    Oncol Rep; 2005 Apr; 13(4):601-6. PubMed ID: 15756430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
    Xiao J; Leung JC; Chan LY; Guo H; Lai KN
    Nephrol Dial Transplant; 2009 Jul; 24(7):2067-77. PubMed ID: 19155534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver.
    Borbath I; Leclercq I; Moulin P; Sempoux C; Horsmans Y
    Eur J Cancer; 2007 Jul; 43(11):1755-63. PubMed ID: 17582756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent effects of peroxisome proliferator-activated receptor-gamma ligands in human and mouse nonalcoholic steatohepatitis.
    Caldwell SH; Argo CK
    Hepatology; 2007 Aug; 46(2):285-7. PubMed ID: 17661403
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered PPARgamma expression and activation after transient focal ischemia in rats.
    Victor NA; Wanderi EW; Gamboa J; Zhao X; Aronowski J; Deininger K; Lust WD; Landreth GE; Sundararajan S
    Eur J Neurosci; 2006 Sep; 24(6):1653-63. PubMed ID: 17004929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor-gamma in pioglitazone mediated chronic gastric ulcer healing in rats.
    Lahiri S; Sen T; Palit G
    Eur J Pharmacol; 2009 May; 609(1-3):118-25. PubMed ID: 19281808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pivotal role of peroxisome proliferator-activated receptor gamma (PPARgamma) in regulation of erythroid progenitor cell proliferation and differentiation.
    Nagasawa E; Abe Y; Nishimura J; Yanase T; Nawata H; Muta K
    Exp Hematol; 2005 Aug; 33(8):857-64. PubMed ID: 16038777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
    Zhang GY; Yi CG; Li X; Ma B; Li ZJ; Chen XL; Guo SZ; Gao WY
    Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Liu D; Zeng BX; Zhang SH; Yao SL
    Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.